Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 473-160-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2016-11-02 to 2016-12-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 473-160-6
- EC Name:
- -
- Molecular formula:
- Hill formula: C24 H15 Cu F2 N7 Na3 O9 S2
- IUPAC Name:
- dicopper(2+) hexasodium 2-[(E)-{[(Z)-(2-{3-[(2,6-difluoropyrimidin-4-yl)amino]-2-oxido-5-sulfonatophenyl}hydrazin-2-id-1-ylidene)(phenyl)methyl]imino}amino]-4-sulfonatobenzoate 2-[(E)-{[(Z)-(2-{3-[(4,6-difluoropyrimidin-2-yl)amino]-2-oxido-5-sulfonatophenyl}hydrazin-2-id-1-ylidene)(phenyl)methyl]imino}amino]-4-sulfonatobenzoate
Constituent 1
- Specific details on test material used for the study:
- Purity: ca 88.0 %
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: TOXI COOP ZRT., 1103 Budapest, Hungary
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 8 weeks
- Weight at study initiation: 192 - 194 g (first step), 203 - 206 g (second step)
- Fasting period before study: overnight (diet)
- Housing: Group caging (3 animals/cage)
- Diet: ssniff® SM R/M-Z+H complete diet ad libitum, ssniff Spezialdiäten GmbH, D-59494 Soest, Germany
- Water: tap water ad libitum
- Acclimation period: 6 days in first step and 7 days in second step
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 30 - 70 %
- Air changes: above 10 air exchanges/hour by central air-condition system
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: November 09, 2016 To: November 25, 2016
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Batch Number: 1608-5511
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw
DOSAGE PREPARATION: Formulations were prepared just before the administration and stirred continuously during the treatment. The correction factor of 1.14 was taken into consideration for the preparation of the test item formulation.
CLASS METHOD
- Rationale for the selection of the starting dose: Starting dose was selected on the basis of the available information about the test item. The acute toxic class method was carried out involving a stepwise procedure with the use of 2000 mg/kg bw as the starting dose in three female rats. No animal died in the first step at 2000 mg/kg bw dose level, so treatment with 2000 mg/kg bw was repeated on further three female rats. No animal died in the second step and thus the test was finished as the stopping criteria of Annex 2d of OECD Guideline No. 423 were met. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 6 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: General state, external appearance, behavior and clinical symptoms after dosing at least once during the first 30 minutes, then 1 h, 2 h, 3 h, 4 h after the treatment and once each day (twice each day for mortality) for 14 days thereafter; body weights on day 0 (just before the treatment), on day 7 and on day 15
- Necropsy of survivors performed: Yes
- Other examinations performed: Macroscopic examination - Statistics:
- Not applicable
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- No deaths occurred after administration of 2000 mg/kg bw.
- Clinical signs:
- other: In group 1 clinical signs of reaction comprised of blue coloured faeces (5 cases of 57 observations) and diarrhoea (3/57). Blue coloured faeces (score +3) was detected in all animals on the treatment day between 2 and 4 hours after the treatment. Diarrho
- Gross pathology:
- Severe hydrometra was found in two females of the group 1 and in one female of group 2. Hydrometra is physiological finding and connected to the cycle of the animal. No pathological changes were found related to the effect of the test item during the macroscopic examination of animals.
- Other findings:
- None
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The oral LD50 in rats was determined to be > 2000 mg/kg bw.
- Executive summary:
An acute toxic class method according to OECD TG 423 was carried out involving a stepwise procedure with the use of 2000 mg/kg bw as the starting dose in three female rats. No animal died in the first step at 2000 mg/kg bw dose level, therefore treatment with 2000 mg/kg bw was repeated on further three female rats. No animal died in the second step, too, so the test was finished, the stopping criteria of Annex 2d of OECD Guideline No. 423 (presented in Appendix VII) was first met. Animals were weighed, observed for lethality and toxic symptoms for 14 days after the treatment. Gross pathological examination was carried out 15th day after the treatment.
No lethality was noted at single oral dose of 2000 mg/kg bw.
In the first step, disturbance of the autonomic functions (diarrhoea) was observed in one animal related with test item effect on the treatment day between 2 and 4 hours after the treatment. However, blue coloured faeces was detected in all animals on the treatment day between 2 and 4 hours after the treatment. This symptom was connected with the physical property of the test item.
In the second step, disturbance of the autonomic functions (diarrhoea) was observed in one animal related with test item effect on the treatment day between 3 and 4 hours after the treatment. However, blue coloured faeces was detected in all animals between the treatment day and Day 1. This symptom was connected with the physical property of the test item.
The body weight development was undisturbed in all animals.
All organs of the animals treated with 2000 mg/kg bw proved to be free of treatment related gross pathological changes.
The oral LD50 in rats was determined to be > 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.